- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A clinician complained that AstraZeneca’s public corporate medicines list showed incorrect/missing black triangle symbols and omitted Imjudo. The Panel found a breach…
Two anonymous Teva representatives alleged excessive call-rate targets and bonus-linked activity created indirect pressure to breach the Code. The Panel found briefing/instructions…
An anonymous representative alleged pressure to promote Aldara off-licence and raised concerns about call-rate targets and a GP letter. The Panel ruled…
Complaint about Lantus promotional materials. Panel ruled multiple presentations of comparative dosing/weight data were misleading due to context and incomplete disclosure, breaching…
A nurse alleged a sponsored symposium discussion implied an EpiPen could replace cardio-pulmonary resuscitation for IV iron reactions. The Panel could not…
A Diabetologia ad for Actos claimed no long-term cardiovascular concerns. The Panel found the claim insufficiently qualified versus the SPC and missing…
Anonymous GP alleged a representative’s hospitality, venue ownership and side businesses created conflicts/inducement concerns. AstraZeneca investigated meetings and payments. Panel raised perception…
Novartis’ UK press release headline implied an overall survival benefit for Femara vs tamoxifen despite non-significant ITT results (p=0.08) and insufficient caveats…
A NeoClarityn journal ad implied clinically supported anti-inflammatory action. PMCPA found it inconsistent with the SPC and misleading, ruling breaches of Clauses…
Anonymous GP complained an osteoporosis audit pushed Adcal-D3. Panel found no inducement, but ruled 2 breaches of Clause 9.1 due to inconsistent/misleading…
Anonymous employee complained Roche incentivised children with cystic fibrosis to stay on Pulmozyme via £10 high-street vouchers. PMCPA found breaches for encouraging…
A urological surgeon said a GSK rep claimed there were no comparative studies between Avodart and finasteride. The Panel found the statement…
Allergan’s Botox monograph made comparative claims vs Dysport (and referenced Xeomin). Panel found several claims misleading/unsubstantiated and ruled Allergan breached the Code,…
A rep left Circadin branded pens/post-its at a children’s centre after meeting a paediatrician. Panel said this fell below the required ethical…
Complaint alleged an unsolicited promotional email to a GP offering six free Distaclor MR starter packs, contrary to DoH out-of-hours guidance. Panel…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.